Overview
ObligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary on its awards, FY2021–FY2025
192 contractor registrations
Five complete fiscal years; FY2026 reported so far is in the trend
Five complete fiscal years; FY2026 reported so far is in the trend
Click a bar to open its page.
Insight 76% under NAICS 325412
Click a company to open its profile.
Insight Other offices funded 0.0%; NAC PHARMACEUTICALS ( ) funded the rest
- California$34.9M · 68%
- Tennessee$12.5M · 24%
- Florida$3.38M · 6.6%
- West Virginia$349K · 0.7%
Insight 68% was performed in California
The latest fiscal year is reported so far (hatched)
Hover over a year to see its value.
Insight $9.18M in FY2025, 19% below FY2021
Each cell is one week of a month: days 1–7, 8–14, 15–21, 22–28 or 29–31
Hover over a week to see its total.
Insight September carried 0.0% of FY2025 obligations
Contractors
Awards it signed and still administers
Click a bar to open its page.
Contractors on NAC PHARMACEUTICALS ( ) awards, FY2021–FY2025
Every company paid on this office's awards; open one to see its other work.
192 contractors received an award; the 25 largest are listed
Showing 1–10 of 25 contractors
| FY2021–FY2025, US$ | ||||
|---|---|---|---|---|
| Share | Last 10 FY | |||
| Golden State Medical Supply, Inc. | 147 | $34,898,145 | 68% | |
| Aphena Pharma Solutions-tennessee, LLC | 20 | $12,504,271 | 24% | |
| Exelan Pharmaceuticals Inc. | 32 | $3,381,972 | 6.6% | |
| Mylan Pharmaceuticals Inc. | 11 | $348,848 | 0.7% | |
| Radha Pharmaceuticals Inc. | 0 | $0 | 0.0% | |
| Fresenius Kabi, LLC | 0 | $0 | 0.0% | |
| Acer Therapeutics Inc. | 0 | $0 | 0.0% | |
| The Harvard Drug Group, L.L.C. | 0 | $0 | 0.0% | |
| Puracap Laboratories LLC | 0 | $0 | 0.0% | |
| Sun Pharmaceutical Industries, Inc. | 0 | $0 | 0.0% | |
Recompetes
Ten largest contracts ending Oct 2026 – Apr 2028, by end date and US$
Click a dot to open its contract.
No contract of this office ends between Oct 20, 2026 and Apr 20, 2028.
Insight
Opportunities
Open opportunities from NAC PHARMACEUTICALS ( )
2 of the next 2 are due within 30 days
Showing 1–2 of 2 opportunities
| Opportunity | Office | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | NAC PHARMACEUTICALS ( ) | Oct 21, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | NAC PHARMACEUTICALS ( ) | Oct 30, 2026 |
Contacts
Small business specialists for NAC PHARMACEUTICALS ( )
- Small business specialistLocked · Data Explorer or any paid plan (name, email and phone with Data Explorer or any paid plan)NAC PHARMACEUTICALS ( )See contacts